Meeting Highlights
Miami, March 27, 2009
Maui, January 14-17, 2009
San Francisco, October 24-29, 2008
Paris, June 11-14, 2008
Chicago, April 10, 2008
San Francisco, March 5-9, 2008
Consumer News
Tuesday, May 06, 2008 Younger People Getting Joint Replacements to Restore Active Lifestyles
A better understanding of joint mechanisms and new technologies allow younger adults to relieve pain with joint replacements…
Thursday, May 01, 2008 Cola May Be Bad to the Bones
High consumption of soda may contribute to lower bone mass and the eventual development of osteoporosis…
Tuesday, April 29, 2008 Women Risk Bone Loss After Knee Surgery
Women who underwent surgery to repair a torn ACL suffered significant bone loss surrounding the knee…
Thursday, April 24, 2008 Pain as an Art Form
Frustrated by the inadequacy of words, chronic pain sufferers often turn to art to illustrate the pain they feel…
Tuesday, April 22, 2008 New Psoriasis Pill Appears Effective
An oral dose of ISA247, a calcineurin inhibitor, shows promise as a safe and effective treatment for moderate to severe psoriasis…
Thursday, April 17, 2008 Splints as Good as Plaster Casts for Minor Fractures
Removable splits are a safe, effective, and cheaper option than traditional plaster casts for minor wrist fractures in children, but are easily tampered with…
Tuesday, April 15, 2008 Novartis Says Aclasta Better at Boosting Bone Mass
Novartis reported study results indicating a once-yearly infusion of Aclasta is more effective than risedronate at increasing bone mass in patients taking steroids...
Thursday, April 10, 2008 Raloxifene Safe for Women With Decreased Kidney Function
The osteoporosis drug raloxifene is safe for women with CKD, effectively promotes bone density, and reduces fractures…
Tuesday, April 08, 2008 Testosterone Therapy May Reduce Bone Loss in Older Men
Testosterone injections may improve bone density and prevent osteoporosis in older men with low testosterone levels…
Thursday, April 03, 2008 Report Claims Clinical Trials Miss Many Populations
Women, minorities, and the elderly are underrepresented in clinical trials...